BIOMAT Database Logo BIOMAT Database Logo

Tumor necrosis factor in alcoholic hepatitis. 1989

J Sweeting

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

J Sweeting
Increased plasma tumor necrosis factor in severe alcoholic hepatitis.
June 1990, Annals of internal medicine,
J Sweeting
Increased tumor necrosis factor production by monocytes in alcoholic hepatitis.
March 1989, Hepatology (Baltimore, Md.),
J Sweeting
Tumor necrosis and alcoholic hepatitis.
August 1991, Hepatology (Baltimore, Md.),
J Sweeting
Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.
April 2003, Journal of hepatology,
J Sweeting
Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis.
May 2000, The Journal of laboratory and clinical medicine,
J Sweeting
Tumor necrosis factor and alcoholic liver disease.
August 1998, Alcoholism, clinical and experimental research,
J Sweeting
Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis.
April 1990, Alcoholism, clinical and experimental research,
J Sweeting
Tumour necrosis factor and polymorphonuclear leukocytes in alcoholic hepatitis.
January 1991, Alcohol and alcoholism (Oxford, Oxfordshire),
J Sweeting
[Monocyte tumor necrosis factor and tumor necrosis factor receptor expression in patients with alcoholic liver cirrhosis].
August 1997, Zhonghua nei ke za zhi,
J Sweeting
Tumor necrosis factor soluble receptor p55 and lipid peroxidation in patients with acute alcoholic hepatitis.
December 2001, The American journal of gastroenterology,
Copied contents to your clipboard!